Testing requirements are likely slowing biosimilar entries in the US
New analysis suggests a high testing bar for biosimilars to gain regulatory approval is another contributing factor for slowing biosimilar … read more »
New executive order brings US IRP closer
President Trump has drawn further criticism from the pharmaceutical industry after signing another executive order aimed at bringing drug prices … read more »
Reports: concern over CDC readying states for vaccine roll-out
The Centers for Disease Control and Prevention (CDC) has written to state health officials to prepare for distribution of some … read more »
AMA pushes for transparency in coronavirus vaccine effort
The American Medical Association (AMA) has cautioned the US Food and Drug Administration (FDA) to ensure its assessment of vaccines … read more »
Pharma presents drug pricing plans to White House
Reports say that the pharmaceutical industry has presented its own plan to reduce drugs spend in the USA in an … read more »
Trump signs pricing orders
President Trump has followed through with a promise to use his Executive powers to bring new rules on pricing to … read more »
USA: Analysis shows States pushing ahead with pricing legislation
A new analysis by Deloitte has shown that States across America have been progressing various forms of drug pricing legislation, … read more »
Trump reported to be readying drug price executive orders
In a Fox News interview, President Trump’s Chief of Staff, Mark Meadows, revealed that three executive orders aimed at lowering … read more »
ICER delves into potential funding models for COVID-19 products
The Institute for Clinical and Economic Review (ICER) has examined a range of funding models that could be used for … read more »
Bipartisan Bill to examine pharma supply chains in the US
Marco Rubio and Elizabeth Warren, US Senators from the Republican and Democratic Parties respectively, have drafted legislation to investigate how … read more »
